TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.

Ajay Subramanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.